Trials of new laser surgery for farsightedness:
This article was originally published in Clinica
Executive Summary
Autonomous Technologies has begun a trial of laser in situ keratomileusis (LASIK) in patients with hyperopia to see if the technique is less painful and offers shorter recovery time than conventional laser surgery. LASIK, in which the surgeon cuts a flap in the cornea, reshapes the tissue underneath using a laser and then replaces the flap, is already widely used in the US for nearsighted patients. The Orlando, Florida-based company has developed a device for tracking the eye and precisely controlling the laser beam.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.